Long-term Follow-up on Childhood Adiposity - The FitKids Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05570396 |
|
Recruitment Status :
Recruiting
First Posted : October 6, 2022
Last Update Posted : October 12, 2022
|
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Submitted Date | September 26, 2022 | ||||||||
| First Posted Date | October 6, 2022 | ||||||||
| Last Update Posted Date | October 12, 2022 | ||||||||
| Actual Study Start Date | October 10, 2022 | ||||||||
| Estimated Primary Completion Date | March 2024 (Final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures |
fat percentage [ Time Frame: Collection from October 2022 until June 2024 ] fat percentage in three-year-old children of mothers who gave birth while still participating in the FitMum study measured by dual energy x-ray absorptiometry and Air Displacement Plethysmography technology
|
||||||||
| Original Primary Outcome Measures | Same as current | ||||||||
| Change History | |||||||||
| Current Secondary Outcome Measures |
|
||||||||
| Original Secondary Outcome Measures | Same as current | ||||||||
| Current Other Pre-specified Outcome Measures | Not Provided | ||||||||
| Original Other Pre-specified Outcome Measures | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title | Long-term Follow-up on Childhood Adiposity - The FitKids Study | ||||||||
| Official Title | Long-term Follow-up on Childhood Adiposity After Randomized Controlled Lifestyle Interventions in Pregnancy - The FitKids Study | ||||||||
| Brief Summary | The FitKids study is a mother-child observational cohort study on obesity and metabolism in children three years of age. The study will follow up on the FitMum and FitBaby studies, conducted from 2018-2022. The children in FitKids are born by mothers who completed the FitMum study, a single-site three-armed RCT, targeting physical activity during pregnancy. 220 pregnant women were randomly assigned to one of three arms during pregnancy: structured supervised exercise training, motivational counselling supported by health technology, or a control group receiving standard treatment. From inclusion and until one-year post-partum, the women wore an activity tracker 24/7 providing important information about adherence to the prescribed intervention. The primary objective of the FitKids study is to investigate the effect of lifestyle interventions during pregnancy on body composition (fat percentage measured by dual energy x-ray absorptiometry) and risk of childhood obesity in off-springs. The secondary objectives are to investigate the effect of lifestyle interventions during pregnancy on obesity-associated dys-metabolic traits and mental health in off-springs as well as to gain insight into presumed causal factors for overweight and obesity in children. The investigators hypothesize that children of mothers, who during their participation in FitMum, received an intervention will have a healthier body composition expressed as a fat percentage within the normal range for a 3-year-old child compared to children of mothers in the control group. |
||||||||
| Detailed Description | Worldwide obesity has nearly tripled since 1975. In 2020, 39 million children under the age of five were overweight or obese. In Denmark approximately 13% of children are overweight or severely overweight by the time they start school. Overweight is generally defined as abnormal fat accumulation and obesity as excessive fat accumulation that may impair health. For children under five years of age, overweight is defined as weight-for-height greater than two standard deviations above World Health Organization (WHO) Child Growth Standards median. Obesity is defined as weight-for-height greater than three standard deviations above the WHO Child Growth Standards median. Childhood obesity is associated with an increased risk of adult obesity, type 2 diabetes, metabolic syndrome, early death and reduced mental health. The large scale of obesity and the serious health problems associated with it calls for more knowledge within the field to prevent children from becoming overweight. Body growth, physical activity, diet, and mental health are focus areas with respect to prevention and treatment of childhood obesity. Current knowledge about both pre- and postnatal factors indicates that being exposed to an adverse fetal environment, including maternal obesity, enhances propagation of obesity and associated cardiometabolic comorbidities, including type 2 diabetes. Still, the evidence is inconsistent and leaves most questions unanswered. Many studies have found strong associations between maternal BMI and their child's BMI. One study showed distinct differences between associations of child BMI with maternal BMI compared to paternal BMI at birth but with the difference between associations diminishing over time. Another study showed associations between maternal pre-pregnancy BMI and child BMI at age five - six years of age. Given this it seems reasonable to suggest that the intrauterine environment is likely associated with the growth trajectory of the young child. It is known that intrauterine exposure to diabetes and size at birth are risk factors for developing type 2 diabetes mellitus later in life, but several studies have also shown that children of mothers with obesity and overweight/obese children are at risk of having early markers of metabolic syndrome, i.e., increased insulin resistance, disturbed lipid profiles and high blood pressure. Lifestyle interventions (physical activity and/or diet) in pregnant women have shown potential to reduce gestational weight gain and are associated with epigenetic changes in the child, potentially influencing the child's lean mass and early growth. However, in a recent metanalysis, prenatal lifestyle interventions were not shown to influence childhood weight or growth, but adherence to prescribed interventions was not systematically considered in the included studies, and only few studies reported data on body composition and metabolism in the child. Therefore, previous studies may not capture more specific effects of prenatal exposures on child fat accretion. Detailed knowledge about maternal lifestyle during pregnancy, combined with advanced measurement of body-composition in children, may contribute to a deeper understanding of how peri- and postnatal factors influence risk of childhood obesity. Body Mass Index (BMI) is strongly correlated with adiposity and the use of age and gender adjusted Body Mass Index (z-BMI) is a crude approximation of excess fat mass. However, BMI z-scores may in some children lead to misclassification of overweight or obesity. BMI has high specificity but low sensitivity to detect excess adiposity and fails to identify more than 25% of children with excess body fat percentage. To overcome the pitfalls associated with BMI, body composition can be measured. Body weight is the sum of fat-mass (FM) and fat-free mass (FFM), and body composition describes the relative proportion of fat-mass and fat-free mass in the body. Experts have not yet identified or agreed upon a definition of obesity that uses an absolute cut-off or threshold for increased body fat mass during childhood. Measuring fat percentage in children is challenging and requires the child to cooperate to the examinations. While Dual-energy X-ray Absorptiometry (DXA) scan is the gold standard, it is well recognized that compliance and cooperation in general is varying in younger children. Therefore, the use of other methods, e.g., air displacement plethysmography (BodPod), may be included in research of childhood obesity. The FitKids-Cohort: The FitKids study is a mother-child observational cohort study on health in children three years of age. The study will follow up on the FitMum (19) and FitBaby studies, conducted from 2018-2022. The children in FitKids are born by mothers who completed the FitMum study, a single-site three-armed randomized controlled trial (RCT), targeting physical activity during pregnancy. 220 previously sedentary, healthy, pregnant women were included in the trial before gestational age (GA) week 15+0. The women had a BMI between 18.5-45 kg/m2 or a weight below 150 kg calculated from pre-pregnancy weight or first measured weight in pregnancy and all had a singleton pregnancy. Included women were randomly assigned to one of three arms during pregnancy: structured supervised exercise training (EXE), motivational counselling supported by health technology (MOT), or a control group receiving standard treatment (CON). From inclusion and until one-year post-partum, the women wore an activity tracker 24/7. This, providing important information about adherence to the prescribed intervention during pregnancy and their general level of activity both during pregnancy and one-year post-partum. All children were invited to participate in The FitBaby study, which includes children who were born by FitMum participants and aims to evaluate the effects of maternal physical activity during pregnancy on health of the child at 12 months. In FitMum and FitBaby, the effects of structured supervised exercise training and motivational counselling during pregnancy on physical activity level and health of mother and child are studied. 44% of FitMum participants were overweight or obese before conception and data regarding gestational weight gain as well as maternal weight during the first-year post-partum have been rigorously collected. The cohort is currently followed up during first year of life in the FitBaby study, and further follow-up in FitKids will add important knowledge about long term effects of the intra- and extrauterine environment on the risk of developing childhood overweight as well as growth, body composition, metabolism, and mental health. The FitKids study is part of The LiP-TOP-Fit consortium consisting of three follow-up studies; LiPO Teen, a follow-up on the 14-15 year-old teenage offspring from the mothers of The Lifestyle in Pregnancy (LiP) study, TOP12, a follow-up on the 12 year old offspring from The Treatment of Obese Pregnant women (TOP) study and FitKids. Together with the FitKids follow up study the synergistic effect of the three follow-up programs in the LiP-TOP-Fit study entails a unique opportunity to understand long-term causal mechanisms of childhood obesity with possible substantially impact for future preventive strategies. Expected outcomes: The FitKids study provides a comprehensive assessment of childhood health, including whole body composition assessed by children anthropometric measures, dual energy x-ray absorptiometry (DXA) and BodPod as well as early markers of metabolic disease assessed by seven-day free-living continuous glucose monitoring, physical activity, blood samples and hair cortisol levels. The children are uniquely well characterized using data from the biological mother during pregnancy and the child from birth until three years of age. Thus, allowing for assessment of fetal and postnatal programming effects. Hence, based on information from the FitMum and FitBaby studies the investigators can investigate early risk factors of later obesity. The longitudinal design allows for investigating trajectories and timing of risk factors, including level of physical activity, body composition and markers of metabolic disease e.g., insulin resistance. The investigators expect that the FitKids study will provide new insights in how body weight and composition in childhood track back to the intrauterine or early postnatal environment. Expected significance of the project to deliver evidence of causal factors: Building upon the RCT design in the FitMum study and the ongoing FitBaby study, the investigators seek to investigate causal relations between the pre- and postnatal environment and childhood health. This can lead to the development of targeted interventions in the prevention of childhood obesity to be implemented at obstetric and/or paediatric departments |
||||||||
| Study Type | Observational | ||||||||
| Study Design | Observational Model: Cohort Time Perspective: Prospective |
||||||||
| Target Follow-Up Duration | Not Provided | ||||||||
| Biospecimen | Not Provided | ||||||||
| Sampling Method | Non-Probability Sample | ||||||||
| Study Population | The research team is still in contact with the participants in FitMum and all children of mothers who completed FitMum will be invited to participate in the FitKids study. The FitMum cohort is 'loyal' as 81% of participants have remained in the study at least until delivery. Therefore, 178 children will be eligible for inclusion and receive an invitation to participate in the FitKids study. A subgroup of the children (n = 147) participated in or are currently participating in the FitBaby study at one year of age. | ||||||||
| Condition |
|
||||||||
| Intervention | Not Provided | ||||||||
| Study Groups/Cohorts | Not Provided | ||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status | Recruiting | ||||||||
| Estimated Enrollment |
178 | ||||||||
| Original Estimated Enrollment | Same as current | ||||||||
| Estimated Study Completion Date | March 2024 | ||||||||
| Estimated Primary Completion Date | March 2024 (Final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria: There are no established exclusion criteria. If a potential participant suffers from a physical or mental illness the decision about participation will be decided together with the parent(s)/custody holder(s). |
||||||||
| Sex/Gender |
|
||||||||
| Ages | 36 Months to 47 Months (Child) | ||||||||
| Accepts Healthy Volunteers | Not Provided | ||||||||
| Contacts |
|
||||||||
| Listed Location Countries | Denmark | ||||||||
| Removed Location Countries | |||||||||
| Administrative Information | |||||||||
| NCT Number | NCT05570396 | ||||||||
| Other Study ID Numbers | H-22018855 | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| U.S. FDA-regulated Product |
|
||||||||
| IPD Sharing Statement | Not Provided | ||||||||
| Current Responsible Party | Grete Katrine Teilmann, Nordsjaellands Hospital | ||||||||
| Original Responsible Party | Same as current | ||||||||
| Current Study Sponsor | Nordsjaellands Hospital | ||||||||
| Original Study Sponsor | Same as current | ||||||||
| Collaborators | Novo Nordisk A/S | ||||||||
| Investigators |
|
||||||||
| PRS Account | Nordsjaellands Hospital | ||||||||
| Verification Date | October 2022 | ||||||||